Authors:
BRUERA E
BELZILE M
PITUSKIN E
FAINSINGER R
DARKE A
HARSANYI Z
BABUL N
FORD I
Citation: E. Bruera et al., RANDOMIZED, DOUBLE-BLIND, CROSS-OVER TRIAL COMPARING SAFETY AND EFFICACY OF ORAL CONTROLLED-RELEASE OXYCODONE WITH CONTROLLED-RELEASE MORPHINE IN PATIENTS WITH CANCER PAIN, Journal of clinical oncology, 16(10), 1998, pp. 3222-3229
Authors:
ONESCHUK D
FAINSINGER R
HANSON J
BRUERA E
Citation: D. Oneschuk et al., ASSESSMENT AND KNOWLEDGE IN PALLIATIVE CARE IN 2ND-YEAR FAMILY MEDICINE RESIDENTS, Journal of pain and symptom management, 14(5), 1997, pp. 265-273
Authors:
BRUERA E
FAINSINGER R
WATANABE S
BELZILE M
Citation: E. Bruera et al., INTERMITTENT SUBCUTANEOUS INJECTIONS (SCI) OF MORPHINE OR HYDROMORPHONE FOR THE MANAGEMENT OF CANCER PAIN, Journal of palliative care, 12(3), 1996, pp. 61-61
Citation: J. Crowther et R. Fainsinger, INCORRECT DIAGNOSIS AND SUBSEQUENT MANAGEMENT OF A PATIENT LABELED WITH CHOLANGIOCARCINOMA, Journal of palliative care, 11(4), 1995, pp. 48-50
Authors:
BRUERA E
FAINSINGER R
SPACHYNSKI K
BABUL N
HARSANYI Z
DARKE AC
Citation: E. Bruera et al., CLINICAL EFFICACY AND SAFETY OF A NOVEL CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN - A RANDOMIZED EVALUATION, Journal of clinical oncology, 13(6), 1995, pp. 1520-1527
Authors:
BRUERA E
FAINSINGER R
SPACHYNSKI K
BABUL N
HARSANYI Z
DARKE AC
Citation: E. Bruera et al., STEADY-STATE PHARMACOKINETIC EVALUATION OF A NOVEL, CONTROLLED-RELEASE MORPHINE SUPPOSITORY AND SUBCUTANEOUS MORPHINE IN CANCER PAIN, Journal of clinical pharmacology, 35(7), 1995, pp. 666-672
Authors:
BRUERA E
VELASCOLEIVA A
SPACHYNSKI K
FAINSINGER R
MILLER MJ
MACEACHERN T
Citation: E. Bruera et al., USE OF THE EDMONTON INJECTOR FOR PARENTERAL OPIOID MANAGEMENT OF CANCER PAIN - A STUDY OF 100 CONSECUTIVE PATIENTS, Journal of pain and symptom management, 8(8), 1993, pp. 525-528